Rational Programming of Cas12a for Early-Stage Detection of COVID-19 by Lateral Flow Assay and Portable Real-Time Fluorescence Readout Facilities
Open Access
- 26 December 2021
- journal article
- research article
- Published by MDPI AG in Biosensors
- Vol. 12 (1) , 11
Abstract
Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus has led to a global pandemic with a high spread rate and pathogenicity. Thus, with limited testing solutions, it is imperative to develop early-stage diagnostics for rapid and accurate detection of SARS-CoV-2 to contain the rapid transmission of the ongoing COVID-19 pandemic. In this regard, there remains little knowledge about the integration of the CRISPR collateral cleavage mechanism in the lateral flow assay and fluorophotometer. In the current study, we demonstrate a CRISPR/Cas12a-based collateral cleavage method for COVID-19 diagnosis using the Cas12a/crRNA complex for target recognition, reverse transcription loop-mediated isothermal amplification (RT-LAMP) for sensitivity enhancement, and a novel DNA capture probe-based lateral flow strip (LFS) or real-time fluorescence detector as the parallel system readout facility, termed CRICOLAP. Our novel approach uses a customized reporter that hybridizes an optimized complementary capture probe fixed at the test line for naked-eye result readout. The CRICOLAP system achieved ultra-sensitivity of 1 copy/µL in ~32 min by portable real-time fluorescence detection and ~60 min by LFS. Furthermore, CRICOLAP validation using 60 clinical nasopharyngeal samples previously verified with a commercial RT-PCR kit showed 97.5% and 100% sensitivity for S and N genes, respectively, and 100% specificity for both genes of SARS-CoV-2. CRICOLAP advances the CRISPR/Cas12a collateral cleavage result readout in the lateral flow assay and fluorophotometer, and it can be an alternative method for the decentralized field-deployable diagnosis of COVID-19 in remote and limited-resource locations.Keywords
Funding Information
- Guangdong Fund Committee for Basic and Applied Basic Research (2019B1515210019)
This publication has 39 references indexed in Scilit:
- Evaluation of CRISPR/Cas12a-based DNA detection for fast pathogen diagnosis and GMO test in riceMolecular Breeding, 2020
- Exploring the Trans‐Cleavage Activity of CRISPR‐Cas12a (cpf1) for the Development of a Universal Electrochemical BiosensorAngewandte Chemie International Edition, 2019
- Development of CRISPR-Cas systems for genome editing and beyondQuarterly Reviews of Biophysics, 2019
- Functionally diverse type V CRISPR-Cas systemsScience, 2019
- Repurposing CRISPR-Cas12b for mammalian genome engineeringCell Discovery, 2018
- CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activityScience, 2018
- Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6Science, 2018
- TUFT1 interacts with RABGAP1 and regulates mTORC1 signalingCell Discovery, 2018
- Nucleic acid detection with CRISPR-Cas13a/C2c2Science, 2017
- Lateral flow nucleic acid biosensor for Cu2+ detection in aqueous solution with high sensitivity and selectivityChemical Communications, 2010